electroCore Provides Update on COVID-19 Clinical Initiatives
Randomized controlled investigator-initiated trial (IIT) of non-invasive vagus nerve stimulation (nVNS) therapy currently enrolling COVID-19 patients in SpainPeer-reviewed paper, “Use […]
Lakeland Financial Reports First Quarter 2020 Performance and Management of COVID-19
WARSAW, Ind., April 27, 2020 (GLOBE NEWSWIRE) — Lakeland Financial Corporation (Nasdaq Global Select/LKFN), parent company of Lake City Bank, […]
CytomX Therapeutics to Announce First Quarter 2020 Financial Results
SOUTH SAN FRANCISCO, Calif., April 27, 2020 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company […]
Middlefield Banc Corp. Reports 2020 First Quarter Financial Results
MIDDLEFIELD, Ohio, April 27, 2020 (GLOBE NEWSWIRE) — Middlefield Banc Corp. (NASDAQ: MBCN) today reported financial results for the 2020 […]
Core-Mark Announces First Quarter 2020 Investor Call
WESTLAKE, Texas, April 27, 2020 (GLOBE NEWSWIRE) — Core-Mark Holding Company, Inc. (NASDAQ: CORE), announced today that it will release […]
Micron Unveils World’s First Open-Source Storage Engine Designed for SSDs and Storage Class Memory
BOISE, Idaho, April 27, 2020 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU), today announced the first open-source, heterogeneous-memory storage […]
DAVIDsTEA Provides Business and Financial Performance Update
MONTREAL, April 27, 2020 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (Nasdaq:DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North […]
SurveyMonkey and COVID Near You Announce Collaboration to Accelerate Coronavirus Research
SAN MATEO, Calif., April 27, 2020 (GLOBE NEWSWIRE) — SurveyMonkey (Nasdaq: SVMK) today announced a new collaboration with COVID Near […]
Atossa Therapeutics Contracts with NYC Health + Hospitals/Metropolitan for COVID-19 HOPE Clinical Study
SEATTLE, April 27, 2020 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and […]
Updated Interim Results from CLASSICAL-Lung, Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer Presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting
ROCHESTER, N.Y., April 27, 2020 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach […]
